Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Scott F, Geller"'
Autor:
Scott F Geller, Karen I Guerin, Meike Visel, Aaron Pham, Edwin S Lee, Amiel A Dror, Karen B Avraham, Toshinori Hayashi, Catherine A Ray, Thomas A Reh, Olivia Bermingham-McDonogh, William J Triffo, Shaowen Bao, Juha Isosomppi, Hanna Västinsalo, Eeva-Marja Sankila, John G Flannery
Publikováno v:
PLoS Genetics, Vol 5, Iss 8, p e1000607 (2009)
Mutations in the CLRN1 gene cause Usher syndrome type 3 (USH3), a human disease characterized by progressive blindness and deafness. Clarin 1, the protein product of CLRN1, is a four-transmembrane protein predicted to be associated with ribbon synaps
Externí odkaz:
https://doaj.org/article/5b0b5b895c4640a499371880eb763eef
Autor:
Juha, Isosomppi, Hanna, Västinsalo, Scott F, Geller, Elise, Heon, John G, Flannery, Eeva-Marja, Sankila
Publikováno v:
Molecular Vision
Purpose Mutations of clarin 1 (CLRN1) cause Usher syndrome type 3 (USH3). To determine the effects of USH3 mutations on CLRN1 function, we examined the cellular distribution and stability of both normal and mutant CLRN1 in vitro. We also searched for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6091dc823179865ea2cf6c6f29c5d33
https://pubmed.ncbi.nlm.nih.gov/19753315
https://pubmed.ncbi.nlm.nih.gov/19753315
Autor:
Scott F, Geller, Jonathan, Stone
Publikováno v:
Advances in experimental medicine and biology. 533
Quantitative polymerase chain reaction (QPCR) was used to examine changes in FosB mRNA expression in models of oxygen and light stress to the retina. C57BL/6 mice or Sprague-Dawley (SD) albino rats were subjected to several experimental paradigms: sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af52beb15b59fd90ec2e63c5715e43b5
https://pubmed.ncbi.nlm.nih.gov/15180271
https://pubmed.ncbi.nlm.nih.gov/15180271
Publikováno v:
Molecular vision. 8
To identify changes in S- and M-sensitive cone opsin gene expression following retinal detachment (RD) and reattachment.Cat retinas were detached for 1, 3, 7, or 28 days, or reattached after 1 h, 1 day, or 3 days of RD and fixed in 4% paraformaldehyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f90327ba9446e2719fe6e20b8cddfcff
https://pubmed.ncbi.nlm.nih.gov/11979236
https://pubmed.ncbi.nlm.nih.gov/11979236
Publikováno v:
Journal of Comparative Neurology; 7/14/2003, Vol. 462 Issue 1, p42-54, 13p